Lipigon Pharmaceuticals AB (publ) (STO:LPGO)
Sweden · Delayed Price · Currency is SEK 0.0060
+0.0004 (7.14%)
At close: Mar 4, 2026
STO:LPGO Market Cap
STO:LPGO has a market cap or net worth of 3.64 million as of March 4, 2026. Its market cap has decreased by -84.80% in one year.
Market Cap
3.64M
Enterprise Value
-12.96M
Revenue
1.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since March 1, 2021, STO:LPGO's market cap has decreased from 97.91M to 3.64M, a decrease of -96.29%. That is a compound annual growth rate of -48.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 3.64M | -30.23% |
| Dec 30, 2025 | 5.21M | -69.56% |
| Dec 30, 2024 | 17.12M | -68.59% |
| Dec 29, 2023 | 54.49M | 240.70% |
| Dec 30, 2022 | 15.99M | -74.72% |
| Dec 30, 2021 | 63.26M | -35.39% |
| Mar 1, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AcouSort AB | 50.16M |
| 2cureX AB | 40.29M |
| Modus Therapeutics Holding AB | 36.12M |
| Nanologica AB | 34.46M |
| Guard Therapeutics International AB | 33.28M |
| ExpreS2ion Biotech Holding AB | 24.18M |
| Aptahem AB | 18.16M |
| Fluicell AB | 16.35M |